Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects

Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects

Autor Helfenstein, T. Google Scholar
Fonseca, FAH Google Scholar
Relvas, WGM Google Scholar
Santos, A. O. Google Scholar
Dabela, M. L. Google Scholar
Matheus, SCP Google Scholar
D'Almeida, V Google Scholar
Tufik, S. Google Scholar
Souza, F. G. Google Scholar
Rodrigues, P. R. Google Scholar
Taglieri, R. Google Scholar
Sousa, E. F. Google Scholar
Izar, MCO Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Background: Hyperhomocysteinemia has emerged as a novel risk factor for myocardial infarction (MI). Some mechanisms proposed to explain its relationship with coronary events are also shared by major coronary risk factors. We examined whether C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms could affect the relative risk for MI.Methods: A sample of 196 individuals was divided into four groups (diabetics with MI, n=43; diabetics without MI, n=50; non-diabetics with MI, n=47; non-diabetics without MI, n=56) and compared regarding the prevalence of the polymorphisms, risk factors, and biochemical parameters.Results: Higher prevalence of hyperhomocysteinemia was found in MI patients (p < 0.05 vs. non-MI subjects), in males (p < 0.001 vs. female) and in those >= 65 years (p=0.01 vs. < 65 years). Homocysteine was negatively associated with HDL-C (p < 0.05) and glucose, although results did not reach significance (p=0.06). Similar distribution of studied polymorphisms was seen in all groups, which presented normal folate and vitamin B12 serum levels.Conclusions: Higher homocysteinemia was predominantly observed in men, presenting low HDL-C, and at advancing age. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms did not contribute to risk assessment in diabetic and non-diabetic subjects presenting normal folate levels. (c) 2005 Elsevier B.V. All rights reserved.
Palavra-chave diabetes mellitus
myocardial infarction
homocysteine
polymorphisms
methylenetetrahydrofolate reductase
methionine synthase
Idioma Inglês
Data de publicação 2005-05-01
Publicado em Clinica Chimica Acta. Amsterdam: Elsevier B.V., v. 355, n. 1-2, p. 165-172, 2005.
ISSN 0009-8981 (Sherpa/Romeo, fator de impacto)
Publicador Elsevier B.V.
Extensão 165-172
Fonte http://dx.doi.org/10.1016/j.cccn.2004.12.002
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000228707500020
Endereço permanente http://repositorio.unifesp.br/handle/11600/28277

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta